Treatment of Cachexia in Gastric Cancer: Exploring the Use of Anti-Inflammatory Natural Products and Their Derivatives
Open Access
Abstract
(1) Background: Gastric cancer is a significant cause of cancer-related mortality worldwide. Weight loss and malnutrition associated with cancer are linked with increased mortality rates and reduced quality of life. Cancer cachexia, characterised by the loss of skeletal muscle, is associated with approximately 20% of cancer-related deaths and differs from malnutrition in that it cannot be fully reversed by nutritional support alone. It is now recognised that the primary pathophysiological process underlying cancer cachexia is chronic inflammation leading to increased calorie consumption. Current treatments that focus on nutritional supplementation, psychological counselling, appetite stimulation and reducing inflammation are lacking in efficacy. This review focuses on the evidence supporting the potential roles of natural anti-inflammatory products and their derivatives including fatty acids, probiotics, amino acids, curcumin, fucoidan, epigallocatechin-3-gallate, ginger, resveratrol and Boswellia serrata in the management of gastric cancer cachexia. (2) Results: While natural anti-inflammatory products show promise in a number of in vitro and in vivo studies, there are only a small number of human studies available. Where present, the evidence base is heterogeneous, with varying study methodologies and outcomes. (3) Conclusions: Natural anti-inflammatory products represent a potential adjunctive therapy for gastric cancer cachexia. Further research, particularly well-designed clinical trials, is needed to elucidate their optimal role, dosing and safety profiles in the management of gastric cancer cachexia.Keywords
This publication has 66 references indexed in Scilit:
- Capsaicin alleviates cisplatin‐induced muscle loss and atrophy in vitro and in vivoJournal of Cachexia, Sarcopenia and Muscle, 2022
- Understanding Cancer Cachexia and Its Implications in Upper Gastrointestinal CancersCurrent Treatment Options in Oncology, 2022
- Approaches to overcome bioavailability inconsistencies of epigallocatechin gallate, a powerful anti-oxidant in green teaFood Chemistry Advances, 2022
- The effect of ginger (Zingiber officinale Roscoe) in patients with advanced cancerSupportive Care in Cancer, 2019
- A phase I study investigating the safety and pharmacokinetics of highly bioavailable curcumin (Theracurmin®) in cancer patientsCancer Chemotherapy and Pharmacology, 2013
- Muscle protein synthesis in cancer patients can be stimulated with a specially formulated medical foodClinical Nutrition, 2011
- Epigallocatechin-3-gallate effectively attenuates skeletal muscle atrophy caused by cancer cachexiaCancer Letters, 2011
- Impact of fish oil and melatonin on cachexia in patients with advanced gastrointestinal cancer: A randomized pilot studyNutrition, 2005
- Phase II study of high‐dose fish oil capsules for patients with cancer‐related cachexiaCancer, 2004
- Improved protein kinetics and albumin synthesis by branched chain amino acid-enriched total parenteral nutrition in cancer cachexia: A prospective randomized crossover trialCancer, 1986